Regions Financial Corp’s AngioDynamics ANGO Stock Holding History

Regions Financial Corp’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$11K	–	865
2019 Q1	$11K	Hold	500	–	–	﹤0.01%	1505
2018 Q4	$10K	Hold	500	–	–	﹤0.01%	1511
2018 Q3	$11K	Hold	500	–	–	﹤0.01%	1595
2018 Q2	$11K	Hold	500	–	–	﹤0.01%	1610
2018 Q1	$9K	Hold	500	–	–	﹤0.01%	1641
2017 Q4	$8K	Buy	+500	New	+$8.53K	﹤0.01%	1715

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Tributary Capital Management Omaha, Nebraska $1.22B AUM 44.12% 1-Year Est. Return

Regions Financial Corp's ANGO Position: Q2 2019 in Review

Regions Financial Corp sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 500 shares — an estimated $11K sold.

Regions Financial Corp first reported a position in ANGO in Q4 2017 and held it in 6 quarters. The position peaked at $11K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

Regions Financial Corp reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
Regions Financial Corp sold 500 AngioDynamics shares in Q2 2019, an estimated $11K.
Regions Financial Corp first reported a position in AngioDynamics in Q4 2017 and held it in 6 quarters.
Regions Financial Corp's AngioDynamics position peaked at $11K in Q1 2019.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.